Seroxat litigation: Sandra Bailey & Ors v GlaxoSmithKline UK
A group action against GlaxoSmithKline UK where claimants are alleged to have suffered withdrawal effects when reducing, discontinuing or attempting to discontinue use of the anti-depressant Seroxat, and that such effects amount to personal injury.
Claimant lawyers:
Hugh James partner partner Mark Harvey instructed 7 Bedford Row’s Simeon Maskrey QC and Julian Matthews.
Defendant lawyers:
Addleshaw Goddard partner John Kelleher instructed Henderson Chambers’ Charles Gibson QC, Prashant Popat QC and Andrew Kinnier to represent GlaxoSmithKline UK.
Hearing date: February for 12-14 weeks.
Judge and court: Mr Justice MacKay; Queen’s Bench Division.
A group action against GlaxoSmithKline UK where claimants are alleged to have suffered withdrawal effects when reducing, discontinuing or attempting to discontinue use of the anti-depressant Seroxat, and that such effects amount to personal injury.
Claimant lawyers:
Hugh James partner partner Mark Harvey instructed 7 Bedford Row’s Simeon Maskrey QC and Julian Matthews.
Defendant lawyers:
Addleshaw Goddard partner John Kelleher instructed Henderson Chambers’ Charles Gibson QC, Prashant Popat QC and Andrew Kinnier to represent GlaxoSmithKline UK.
Hearing date: February for 12-14 weeks.
Judge and court: Mr Justice MacKay; Queen’s Bench Division.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.